Annals of Oncology
(ANN ONCOL) 《肿瘤学年鉴》

网友评分点击次数：1256

2012年影响因子
7.384

全球精选全文

2012-10-10•聚焦三阴乳腺癌：优化治疗结果
2012-10-10•饮酒和肾细胞癌风险：一项meta分析的结果
2012-10-10•1978-2005英国儿童期癌症人群生存期按进入临床研究时代分类
2012-10-10•基底样和三阴侵袭性乳腺癌中钙蛋白酶系统蛋白表达
2012-10-10•肺癌中的骨问题
2012-10-10•集中病理学评价对个体化患者乳腺癌淋巴结分级的相关影响

中国作者重要发表

Published 2012年9月,Volume 23,Issue 9

reviews

Select this article
- T. Brodowicz,
- K. O'Byrne,
- and C. Manegold
Bone matters in lung cancer
Ann Oncol (2012) 23(9): 2215-2222 doi:10.1093/annonc/mds009
- Abstract
- Full Text (HTML)
- Full Text (PDF)
OPEN ACCESS
Select this article
- K. Gelmon,
- R. Dent,
- J. R. Mackey,
- K. Laing,
- D. McLeod,
- and S. Verma
Targeting triple-negative breast cancer: optimising therapeutic outcomes
Ann Oncol (2012) 23(9): 2223-2234 doi:10.1093/annonc/mds067
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions
Select this article
- R. Bellocco,
- E. Pasquali,
- M. Rota,
- V. Bagnardi,
- I. Tramacere,
- L. Scotti,
- C. Pelucchi,
- P. Boffetta,
- G. Corrao,
- and C. La Vecchia
Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis
Ann Oncol (2012) 23(9): 2235-2244 doi:10.1093/annonc/mds022
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions

original articles

lung cancer

Select this article
- W. E. Pierceall,
- K. A. Olaussen,
- V. Rousseau,
- E. Brambilla,
- K. M. Sprott,
- F. Andre,
- J.-P. Pignon,
- T. Le Chevalier,
- R. Pirker,
- C. Jiang,
- M. Filipits,
- Y. Chen,
- J. L. Kutok,
- D. T. Weaver,
- B. E. Ward,
- and J.-C. Soria
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses
Ann Oncol (2012) 23(9): 2245-2252 doi:10.1093/annonc/mdr624
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions
Select this article
- S. Niho,
- Y. Ohe,
- S. Ishikura,
- S. Atagi,
- A. Yokoyama,
- Y. Ichinose,
- H. Okamoto,
- K. Takeda,
- T. Shibata,
- T. Tamura,
- N. Saijo,
- and M. Fukuoka
Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402)
Ann Oncol (2012) 23(9): 2253-2258 doi:10.1093/annonc/mds012
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions

gynecologic tumors

Select this article
- J. Sehouli,
- I. B. Runnebaum,
- C. Fotopoulou,
- U. Blohmer,
- A. Belau,
- H. Leber,
- L. C. Hanker,
- W. Hartmann,
- R. Richter,
- M. D. Keyver-Paik,
- C. Oberhoff,
- G. Heinrich,
- A. du Bois,
- C. Olbrich,
- E. Simon,
- K. Friese,
- R. Kimmig,
- D. Boehmer,
- W. Lichtenegger,
- and S. Kuemmel
A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study
Ann Oncol (2012) 23(9): 2259-2264 doi:10.1093/annonc/mdr628
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Permissions
Select this article
- K. H. Baumann,
- A. du Bois,
- W. Meier,
- J. Rau,
- P. Wimberger,
- J. Sehouli,
- C. Kurzeder,
- F. Hilpert,
- A. Hasenburg,
- U. Canzler,
- L. C. Hanker,
- P. Hillemanns,
- B. Richter,
- K. Wollschlaeger,
- T. Dewitz,
- D. Bauerschlag,
- and U. Wagner
A phase II trial (AGO 2.11) in platinum-resistant ovarian cancer: a randomized multicenter trial with sunitinib (SU11248) to evaluate dosage, schedule, tolerability, toxicity and effectiveness of a multitargeted receptor tyrosine kinase inhibitor monotherapy
Ann Oncol (2012) 23(9): 2265-2271 doi:10.1093/annonc/mds003
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Permissions

breast cancer

Select this article
- E.-F. Solomayer,
- G. Gebauer,
- P. Hirnle,
- W. Janni,
- H.-J. Lück,
- S. Becker,
- J. Huober,
- B. Krämer,
- B. Wackwitz,
- D. Wallwiener,
- and T. Fehm
Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients
Ann Oncol (2012) 23(9): 2271-2277 doi:10.1093/annonc/mdr612
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Permissions
Select this article
- M. Bernsdorf,
- A. K. Berthelsen,
- V. T. Wielenga,
- N. Kroman,
- D. Teilum,
- T. Binderup,
- U. B. Tange,
- M. Andersson,
- A. Kjær,
- A. Loft,
- and J. Graff
Preoperative PET/CT in early-stage breast cancer
Ann Oncol (2012) 23(9): 2277-2282 doi:10.1093/annonc/mds002
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions
Select this article
- I. H. Park,
- H. S. Han,
- H. Lee,
- K. S. Lee,
- H. S. Kang,
- S. Lee,
- S. W. Kim,
- S. Jung,
- and J. Ro
Resumption or persistence of menstruation after cytotoxic chemotherapy is a prognostic factor for poor disease-free survival in premenopausal patients with early breast cancer
Ann Oncol (2012) 23(9): 2283-2289 doi:10.1093/annonc/mds006
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions
Select this article
- S. J. Storr,
- K. W. Lee,
- C. M. Woolston,
- S. Safuan,
- A. R. Green,
- R. D. Macmillan,
- A. Benhasouna,
- T. Parr,
- I. O. Ellis,
- and S. G. Martin
Calpain system protein expression in basal-like and triple-negative invasive breast cancer
Ann Oncol (2012) 23(9): 2289-2296 doi:10.1093/annonc/mds176
- Abstract
- Full Text (HTML)
- Full Text (PDF)
OPEN ACCESS
Select this article
- S. J. Johnston,
- F. S. Kenny,
- B. M. Syed,
- J. F. R. Robertson,
- S. E. Pinder,
- L. Winterbottom,
- I. O. Ellis,
- R. W. Blamey,
- and K. L. Cheung
A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up
Ann Oncol (2012) 23(9): 2296-2300 doi:10.1093/annonc/mdr630
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Permissions
Select this article
- A. M. M. Oonk,
- C. van Rijn,
- M. M. Smits,
- L. Mulder,
- N. Laddach,
- S. P. Savola,
- J. Wesseling,
- S. Rodenhuis,
- A. L. T. Imholz,
- and E. H. Lips
Clinical correlates of ‘BRCAness’ in triple-negative breast cancer of patients receiving adjuvant chemotherapy
Ann Oncol (2012) 23(9): 2301-2305 doi:10.1093/annonc/mdr621
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Permissions
Select this article
- M. Schmidt,
- D. Rüttinger,
- M. Sebastian,
- C. A. Hanusch,
- N. Marschner,
- P. A. Baeuerle,
- A. Wolf,
- G. Göppel,
- D. Oruzio,
- G. Schlimok,
- G. G. Steger,
- C. Wolf,
- W. Eiermann,
- A. Lang,
- and M. Schuler
Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer
Ann Oncol (2012) 23(9): 2306-2313 doi:10.1093/annonc/mdr625
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions

gastrointestinal tumors

Select this article
- D. Santini,
- B. Vincenzi,
- R. Addeo,
- C. Garufi,
- G. Masi,
- M. Scartozzi,
- A. Mancuso,
- A. M. Frezza,
- O. Venditti,
- M. Imperatori,
- G. Schiavon,
- G. Bronte,
- G. Cicero,
- F. Recine,
- E. Maiello,
- S. Cascinu,
- A. Russo,
- A. Falcone,
- and G. Tonini
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
Ann Oncol (2012) 23(9): 2313-2318 doi:10.1093/annonc/mdr623
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Permissions
Select this article
- A. P. Keszei,
- L. J. Schouten,
- R. A. Goldbohm,
- and P. A. van den Brandt
Red and processed meat consumption and the risk of esophageal and gastric cancer subtypes in The Netherlands Cohort Study
Ann Oncol (2012) 23(9): 2319-2326 doi:10.1093/annonc/mdr615
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions
Select this article
- J. B. Bachet,
- R. Maréchal,
- P. Demetter,
- F. Bonnetain,
- A. Couvelard,
- M. Svrcek,
- A. Bardier-Dupas,
- P. Hammel,
- A. Sauvanet,
- C. Louvet,
- F. Paye,
- P. Rougier,
- C. Penna,
- J. C. Vaillant,
- T. André,
- J. Closset,
- I. Salmon,
- J. F. Emile,
- and J. L. Van Laethem
Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma
Ann Oncol (2012) 23(9): 2327-2335 doi:10.1093/annonc/mdr617
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions
Select this article
- J. R. Strosberg,
- J. M. Weber,
- J. Choi,
- T. L. Campos,
- T. L. Valone,
- G. Han,
- M. J. Schell,
- and L. K. Kvols
A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors
Ann Oncol (2012) 23(9): 2335-2341 doi:10.1093/annonc/mdr614
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Permissions
Select this article
- L. H. Jensen,
- J. Lindebjerg,
- J. Ploen,
- T. F. Hansen,
- and A. Jakobsen
Phase II marker-driven trial of panitumumab and chemotherapy in KRASwild-type biliary tract cancer
Ann Oncol (2012) 23(9): 2341-2346 doi:10.1093/annonc/mds008
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Permissions

urogenital tumors

Select this article
- S. X. Bian,
- D. A. Kuban,
- L. B. Levy,
- J. Oh,
- K. O. Castle,
- T. J. Pugh,
- S. Choi,
- S. E. McGuire,
- Q. N. Nguyen,
- S. J. Frank,
- P. L. Nguyen,
- A. K. Lee,
- and K. E. Hoffman
Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer
Ann Oncol (2012) 23(9): 2346-2352 doi:10.1093/annonc/mds001
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Permissions
Select this article
- P. Gazzaniga,
- A. Gradilone,
- E. de Berardinis,
- G. M. Busetto,
- C. Raimondi,
- O. Gandini,
- C. Nicolazzo,
- A. Petracca,
- B. Vincenzi,
- A. Farcomeni,
- V. Gentile,
- E. Cortesi,
- and L. Frati
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis
Ann Oncol (2012) 23(9): 2352-2356 doi:10.1093/annonc/mdr619
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Permissions

hematologic malignancies

Select this article
- M. S. Czuczman,
- J. P. Leonard,
- S. Jung,
- J. L. Johnson,
- E. D. Hsi,
- J. C. Byrd,
- andB. D. Cheson
Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness
Ann Oncol (2012) 23(9): 2356-2362 doi:10.1093/annonc/mdr620
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Permissions
Select this article
- E. V. Kane,
- E. Roman,
- N. Becker,
- L. Bernstein,
- P. Boffetta,
- P. M. Bracci,
- J. R. Cerhan,
- B. C. -H. Chiu,
- P. Cocco,
- L. Costas,
- L. Foretova,
- E. A. Holly,
- C. La Vecchia,
- K. Matsuo,
- M. Maynadie,
- S. Sanjose,
- J. J. Spinelli,
- A. Staines,
- R. Talamini,
- S. S. Wang,
- Y. Zhang,
- T. Zheng,
- A. Kricker,
- and for the InterLymph Consortium
Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case–control studies
Ann Oncol (2012) 23(9): 2362-2374 doi:10.1093/annonc/mds171
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Permissions
Select this article
- A. Korfel,
- M. Weller,
- P. Martus,
- P. Roth,
- H. A. Klasen,
- A. Roeth,
- M. Rauch,
- B. Hertenstein,
- T. Fischer,
- T. Hundsberger,
- M. Leithäuser,
- T. Birnbaum,
- H. Kirchen,
- H.-G. Mergenthaler,
- J. Schubert,
- W. Berdel,
- J. Birkmann,
- M. Hummel,
- E. Thiel,
- and L. Fischer
Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial
Ann Oncol (2012) 23(9): 2374-2380 doi:10.1093/annonc/mdr627
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Permissions
Select this article
- P. Colombat,
- N. Brousse,
- G. Salles,
- F. Morschhauser,
- P. Brice,
- P. Soubeyran,
- V. Delwail,
- E. Deconinck,
- C. Haioun,
- C. Foussard,
- C. Sebban,
- H. Tilly,
- C. Thieblemont,
- L. Bergougnoux,
- F. Lazreg,
- and P. Solal-Celigny
Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up
Ann Oncol (2012) 23(9): 2380-2385 doi:10.1093/annonc/mds177
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions
Select this article
- F. Garban,
- S. Carras,
- P. Drillat,
- M. C. Jacob,
- B. Fabre,
- M. Callanan,
- S. Courby,
- C. Makowski,
- J. Y. Cahn,
- and R. Gressin
Extracorporeal photopheresis as a curative treatment strategy in non epidermotropic T-cell lymphoma and large granular lymphocyte leukemia
Ann Oncol (2012) 23(9): 2386-2390 doi:10.1093/annonc/mds014
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Permissions

head and neck cancer

Select this article
- D. J. Sher,
- V. Thotakura,
- T. A. Balboni,
- C. M. Norris,
- R. I. Haddad,
- M. R. Posner,
- J. Lorch,
- L. A. Goguen,
- D. J. Annino,
- and R. B. Tishler
Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy
Ann Oncol (2012) 23(9): 2391-2398 doi:10.1093/annonc/mdr609
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions

phase I and pharmacokinetics

Select this article
- B. Markman,
- J. Tabernero,
- I. Krop,
- G. I. Shapiro,
- L. Siu,
- L. C. Chen,
- M. Mita,
- M. Melendez Cuero,
- S. Stutvoet,
- D. Birle,
- Ö. Anak,
- W. Hackl,
- and J. Baselga
Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors
Ann Oncol (2012) 23(9): 2399-2408 doi:10.1093/annonc/mds011
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions

translational research

Select this article
- L. Schirosi,
- N. Nannini,
- D. Nicoli,
- A. Cavazza,
- R. Valli,
- S. Buti,
- L. Garagnani,
- G. Sartori,
- F. Calabrese,
- A. Marchetti,
- F. Buttitta,
- L. Felicioni,
- M. Migaldi,
- F. Rea,
- F. Di Chiara,
- M. C. Mengoli,
- and G. Rossi
Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors
Ann Oncol (2012) 23(9): 2409-2414 doi:10.1093/annonc/mdr626
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions
Select this article
- Y. Li,
- T. Jiang,
- J. Zhang,
- B. Zhang,
- W. Yang,
- G. You,
- K. Xu,
- J. Wu,
- C. Luo,
- andS. W. Song
Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies
Ann Oncol (2012) 23(9): 2415-2422 doi:10.1093/annonc/mds007
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions

epidemiology

Select this article
- E. P. Stavrou,
- C. Y. Lu,
- N. Buckley,
- and S. Pearson
The role of comorbidities on the uptake of systemic treatment and 3-year survival in older cancer patients
Ann Oncol (2012) 23(9): 2422-2428 doi:10.1093/annonc/mdr618
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions
Select this article
- D. Pulte,
- M. T. Redaniel,
- H. Brenner,
- and M. Jeffreys
Changes in survival by ethnicity of patients with cancer between 1992–1996 and 2002–2006: is the discrepancy decreasing?
Ann Oncol (2012) 23(9): 2428-2434 doi:10.1093/annonc/mds023
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions
Select this article
- T. Islam,
- K. Matsuo,
- H. Ito,
- S. Hosono,
- M. Watanabe,
- H. Iwata,
- K. Tajima,
- andH. Tanaka
Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women
Ann Oncol (2012) 23(9): 2435-2441 doi:10.1093/annonc/mdr613
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions

sarcomas

Select this article
- I. Ray-Coquard,
- M. C. Montesco,
- J. M. Coindre,
- A. P. Dei Tos,
- A. Lurkin,
- D. Ranchère-Vince,
- A. Vecchiato,
- A. V. Decouvelaere,
- S. Mathoulin-Pélissier,
- S. Albert,
- P. Cousin,
- D. Cellier,
- L. Toffolatti,
- C. R. Rossi,
- and J. Y. Blay
Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions
Ann Oncol (2012) 23(9): 2442-2449 doi:10.1093/annonc/mdr610
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions
Select this article
- A. H. Choi,
- J. S. Barnholtz-Sloan,
- and J. A. Kim
Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted SEER analysis
Ann Oncol (2012) 23(9): 2449-2457 doi:10.1093/annonc/mdr616
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Permissions

pediatric malignancies

Select this article
- K. Pritchard-Jones,
- V. Moroz,
- G. Vujanić,
- M. Powis,
- J. Walker,
- B. Messahel,
- R. Hobson,
- G. Levitt,
- A. Kelsey,
- C. Mitchell,
- and on behalf of the Children's Cancer and Leukaemia Group (CCLG) Renal Tumours Group
Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial
Ann Oncol (2012) 23(9): 2457-2463 doi:10.1093/annonc/mds025
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Permissions
Select this article
- C. A. Stiller,
- M. E. Kroll,
- and K. Pritchard-Jones
Population survival from childhood cancer in Britain during 1978–2005 by eras of entry to clinical trials
Ann Oncol (2012) 23(9): 2464-2469 doi:10.1093/annonc/mds183
- Abstract
- Full Text (HTML)
- Full Text (PDF)
- Supplementary Data
- Permissions

letter to the editor

Select this article
- C. F. Xu,
- Z. Xue,
- N. Bing,
- K. S. King,
- L. A. McCann,
- P. L. de Souza,
- V. L. Goodman,
- C. F. Spraggs,
- V. E. Mooser,
- and L. N. Pandite
Concomitant use of pazopanib and simvastatin increases the risk of transaminase elevations in patients with cancer
Ann Oncol (2012) 23(9): 2470-2471 doi:10.1093/annonc/mds249
- Extract
- Full Text (HTML)
- Full Text (PDF)
- Permissions

过刊浏览

发表评论网友评论(13)

期刊中心

Annals of Oncology (ANN ONCOL) 《肿瘤学年鉴》

全球精选全文

中国作者重要发表

最新一期

DNA repair protein expression in resected NSCLC: a different predictive value for platinum benefit in adenocarcinoma versus squamous-cell carcinoma?

reviews

Bone matters in lung cancer

Targeting triple-negative breast cancer: optimising therapeutic outcomes

Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis

original articles

lung cancer

Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses

Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402)

gynecologic tumors

A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study

A phase II trial (AGO 2.11) in platinum-resistant ovarian cancer: a randomized multicenter trial with sunitinib (SU11248) to evaluate dosage, schedule, tolerability, toxicity and effectiveness of a multitargeted receptor tyrosine kinase inhibitor monotherapy

breast cancer

Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients

Preoperative PET/CT in early-stage breast cancer

Resumption or persistence of menstruation after cytotoxic chemotherapy is a prognostic factor for poor disease-free survival in premenopausal patients with early breast cancer

Calpain system protein expression in basal-like and triple-negative invasive breast cancer

A randomised trial of primary tamoxifen versus mastectomy plus adjuvant tamoxifen in fit elderly women with invasive breast carcinoma of high oestrogen receptor content: long-term results at 20 years of follow-up

Clinical correlates of ‘BRCAness’ in triple-negative breast cancer of patients receiving adjuvant chemotherapy

Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer

gastrointestinal tumors

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

Red and processed meat consumption and the risk of esophageal and gastric cancer subtypes in The Netherlands Cohort Study

Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma

A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors

Phase II marker-driven trial of panitumumab and chemotherapy in KRASwild-type biliary tract cancer

urogenital tumors

Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer

Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis

hematologic malignancies

Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness

Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case–control studies

Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial

Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up

Extracorporeal photopheresis as a curative treatment strategy in non epidermotropic T-cell lymphoma and large granular lymphocyte leukemia

head and neck cancer

Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy

phase I and pharmacokinetics

Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors

translational research

Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors

Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies

epidemiology

The role of comorbidities on the uptake of systemic treatment and 3-year survival in older cancer patients

Changes in survival by ethnicity of patients with cancer between 1992–1996 and 2002–2006: is the discrepancy decreasing?

Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women

sarcomas

Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions

Effect of radiation therapy on survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted SEER analysis

pediatric malignancies

Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial

Population survival from childhood cancer in Britain during 1978–2005 by eras of entry to clinical trials

letter to the editor

Concomitant use of pazopanib and simvastatin increases the risk of transaminase elevations in patients with cancer

过刊浏览

同类期刊影响因子排行

Annals of Oncology
(ANN ONCOL) 《肿瘤学年鉴》